DashboardAll companies
Run this on your own research
Healthcare · Drug Manufacturers - General

Pfizer Inc.

PFENYSE$30.03−$0.39 (−1.28%)Pre-market

Price Chart

Daily

Key facts

Market Cap
$171.14B
P/E
22.0x
P/B
1.97x
ROE
8.9%

Pfizer Inc.

Healthcare · Drug Manufacturers - General · FY 2025

Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sector, Pfizer focuses on creating innovative medicines and vaccines that significantly improve patients' lives. It is renowned for its contributions to pivotal health areas, such as oncology, immunology, cardiovascular health, and rare diseases. Pfizer maintains a robust pipeline of products at various stages of clinical development, enhancing its market position and impact. The company is instrumental in the global pharmaceutical landscape, contributing to public health with breakthroughs like vaccines and therapies that tackle some of the world's most challenging diseases. Headquartered in New York City, Pfizer plays a critical role in addressing urgent medical needs worldwide and is involved in extensive collaborations with scientific communities and healthcare systems. As a key player in the pharmaceutical industry, Pfizer’s developments and strategic initiatives can influence market trends and health policies, underscoring its importance in the global effort to combat health issues.

CEO
Dr. Albert Bourla D.V.M., Ph.D.
Employees
81,000
Website
pfizer.com

Company Statistics

Valuation

P/E
22.0x
P/B
1.97x
P/S
2.73x
EV/EBITDA
9.1x
P/FCF
18.8x

Margins

Gross
74.3%
EBITDA
41.1%
Operating
27.8%
Pre-Tax
12.0%
Net
12.5%

Returns

ROA
3.7%
ROE
8.9%
ROIC
4.8%

Growth (CAGR)

Rev 3Yr
−14.6%
Rev 5Yr
8.5%
Op Inc 3Yr
−22.4%
Net Inc 3Yr
−37.1%

Financial Health

Cash & Cash Equivalents
$1.14B
Net Debt
$120.24B
Debt/Equity
139.9%
Interest Cov
—

Profile

Revenue
$62.58B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Pfizer Inc. (PFE) Stock Forecast 2026 $30.03 — Price, Financials & Analyst Targets | AlphaLenz